1. Home
  2. THAR vs WNW Comparison

THAR vs WNW Comparison

Compare THAR & WNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THAR
  • WNW
  • Stock Information
  • Founded
  • THAR 2017
  • WNW 2015
  • Country
  • THAR United States
  • WNW China
  • Employees
  • THAR N/A
  • WNW N/A
  • Industry
  • THAR Biotechnology: Pharmaceutical Preparations
  • WNW Catalog/Specialty Distribution
  • Sector
  • THAR Health Care
  • WNW Consumer Discretionary
  • Exchange
  • THAR Nasdaq
  • WNW Nasdaq
  • Market Cap
  • THAR 5.5M
  • WNW 5.7M
  • IPO Year
  • THAR 2022
  • WNW 2020
  • Fundamental
  • Price
  • THAR $1.46
  • WNW $1.85
  • Analyst Decision
  • THAR Strong Buy
  • WNW
  • Analyst Count
  • THAR 1
  • WNW 0
  • Target Price
  • THAR $17.00
  • WNW N/A
  • AVG Volume (30 Days)
  • THAR 43.3K
  • WNW 55.5K
  • Earning Date
  • THAR 08-08-2025
  • WNW 08-05-2025
  • Dividend Yield
  • THAR N/A
  • WNW N/A
  • EPS Growth
  • THAR N/A
  • WNW N/A
  • EPS
  • THAR N/A
  • WNW 9.06
  • Revenue
  • THAR N/A
  • WNW $158,485.00
  • Revenue This Year
  • THAR N/A
  • WNW N/A
  • Revenue Next Year
  • THAR N/A
  • WNW N/A
  • P/E Ratio
  • THAR N/A
  • WNW $0.21
  • Revenue Growth
  • THAR N/A
  • WNW N/A
  • 52 Week Low
  • THAR $0.95
  • WNW $0.95
  • 52 Week High
  • THAR $6.39
  • WNW $70.00
  • Technical
  • Relative Strength Index (RSI)
  • THAR 39.40
  • WNW 51.47
  • Support Level
  • THAR $1.60
  • WNW $1.82
  • Resistance Level
  • THAR $1.75
  • WNW $1.90
  • Average True Range (ATR)
  • THAR 0.10
  • WNW 0.08
  • MACD
  • THAR -0.04
  • WNW 0.00
  • Stochastic Oscillator
  • THAR 1.01
  • WNW 65.22

About THAR Tharimmune Inc.

Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.

About WNW Meiwu Technology Company Limited

Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.

Share on Social Networks: